Picture of Fresh Tracks Therapeutics logo

FRTX — Fresh Tracks Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapTurnaround

Brief: Brickell Biotech Reports Q1 2022 Results And Provides Corporate Update

May 12 (Reuters) - Brickell Biotech Inc  BBI.O :
    * BRICKELL BIOTECH REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * BRICKELL BIOTECH- EXPECTS CASH, CASH EQUIVALENTS AS OF
MARCH 31,
2022,PAYMENTS UNDER DEAL WITH BOTANIX TO SUPPORT OPERATIONS FOR
AT LEAST NEXT 12 MONTHS
    * BRICKELL BIOTECH INC - QTRLY LOSS PER SHARE $0.08

Source text for Eikon:  ID:nGNX3Clthh 
Further company coverage:  BBI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Fresh Tracks Therapeutics

See all news